13F Holdings
中文EN

RCEL AVITA Medical, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1762303 · Fiscal year ends 12/31

Financial factors as of 2025-09-30 (2025Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY20.6%
TTM net income YoY15.3%
TTM EPS YoY18.8%
Revenue 3-yr CAGR31.4%
Net income 3-yr CAGR—

Margins

Gross margin83.7%
Operating margin-58.1%
Net margin-67.1%
FCF margin-51.3%
EBITDA margin-55.7%

Returns

ROE-1,746.3%
ROA-67.1%
ROIC (approx.)-117.7%
Asset turnover1.00x

Leverage & solvency

Liabilities / assets110.5%
Debt / equity—
Current ratio0.67x
Interest coverage-8.33x

Cash quality & payout

Operating cash flow / net income0.70x
Accruals ratio-20.3%
Payout ratio—
Capex / revenue4.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-06-30
Income statement
Revenue$71.61M$64.25M$50.14M$34.42M$29.23M
Cost of revenue$12.79M$9.09M$7.78M$6.04M$5.95M
Gross profit$58.82M$55.16M$42.36M$28.38M$23.28M
R&D expense$20.84M$20.36M$20.82M$13.86M$14.82M
SG&A expense$27.37M$33.20M$28.33M$23.33M$22.40M
Operating income-$42.53M-$56.59M-$42.66M-$27.50M-$26.54M
Interest expense$5.00M$5.36M$1.14M$16,000$22,000
Pretax income-$48.58M-$61.79M-$35.31M-$26.63M-$26.55M
Income tax$11,000$54,000$66,000$36,000$38,000
Net income-$48.59M-$61.84M-$35.38M-$26.66M-$26.58M
EBITDA-$40.19M-$55.47M-$42.02M-$26.94M-$25.82M
EPS (basic)-1.74-2.39-1.401.071.17
EPS (diluted)-1.74-2.39-1.401.071.17
Weighted avg. shares (diluted)27.86M25.88M25.33M25.00M22.67M
Banking
Provision for credit losses-$10,000$23,000$24,000-$5,000$12,000
Balance sheet
Cash & equivalents$10.24M$14.05M$22.12M$18.16M$110.75M
Short-term investments$7.94M$21.84M$66.94M$61.18M—
Receivables$9.09M$11.80M$7.66M$3.52M$3.47M
Inventory$6.93M$7.27M$5.60M$2.12M$1.65M
Current assets$35.49M$57.00M$104.01M$87.46M$121.33M
PP&E, net$8.63M$10.02M$1.88M$1.20M$1.46M
Intangibles$5.64M$5.57M$487,000$465,000$472,000
Total assets$56.39M$79.71M$111.64M$98.26M$125.50M
Current liabilities$62.68M$20.16M$13.20M$10.69M$7.39M
Short-term debt$42.98M$0———
Long-term debt$0$42.24M$39.81M——
Total debt$42.98M$42.24M$39.81M——
Total liabilities$73.04M$74.97M$61.89M$12.97M$9.85M
Shareholders' equity-$16.65M$4.50M$49.06M$84.74M$115.66M
Net debt$32.74M$28.20M$17.69M——
Shares outstanding30.57M26.35M25.68M25.21M24.90M
Cash flow statement
Operating cash flow-$31.20M-$48.94M-$38.01M-$19.09M-$25.90M
Capital expenditure$1.00M$9.17M$1.38M$452,000$894,000
Free cash flow-$32.20M-$58.11M-$39.39M-$19.54M-$26.80M
Investing cash flow$12.45M$37.36M$1.61M-$19.33M-$1.17M
Financing cash flow$14.94M$3.51M$40.37M$900,000$64.05M
Depreciation & amortization$2.35M$1.13M$632,000$568,000$715,000
Stock-based compensation$9.52M$13.50M$8.38M$7.00M$5.66M

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.